Plain-English translation of NCT05793333 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand which endometrial cancer patients are at higher risk of cancer spreading to their lymph nodes. By studying the genetic and physical characteristics of your tumor, along with your sentinel node mapping results (a procedure that checks nearby lymph nodes for cancer), they hope to develop better ways to predict which patients need additional treatment or closer monitoring.
Not all endometrial cancer patients have cancer that spreads to lymph nodes, but doctors currently have limited ways to predict who will and who won't. This trial aims to create a more accurate prediction tool using tumor genetics and appearance, which could help doctors make better treatment decisions and avoid unnecessary procedures for some patients.
You likely qualify if…
You likely don't qualify if…
This is not a treatment trial — you are not receiving any new medication or procedure. Instead, researchers will review your existing medical records, including your tumor biopsy results, genetic testing data, and sentinel node mapping results. You may need to complete a consent form, and researchers may ask you questions about your medical history. The study collects information that has already been gathered as part of your standard cancer care.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Italy
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Enrollment target
~200 participants
Started
January 2022
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in September 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Grazia M Casadei, ph.d.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.